Chemical products

Tender description

The University of Nottingham invites tenders from sufficiently experienced, qualified suppliers to establish a framework agreement for provision of laboratory chemicals and consumables (including pipettes, tips and servicing) initially 2 years with options to extend for 2 x 12 months. The framework also to be available for use by Universities of Derby, Exeter, and Warwick, the estimated total value at ll.1.5) includes their potential spend. The specific requirements detailed within the ITT documents are those of the University of Nottingham. The framework is split into 11 lots as follows: Lot 1: Chemicals, Lot 2: Bio-chemicals, Lot 3: Tissue Cultures, Lot 4: General Consumables, Lot 5: PPE and Cleaning, Lot 6: Pipettes, Tips and Servicing, Lot 7: Glassware and Ground Glass, Lot 8: Plastics, Lot 9: Tissue Culture Plastics, Lot 10: Oligos and Primers, Lot 11: DNA Sequencing. Each lot may be awarded to up to five suppliers, however lot 1, 2 and 8 may be awarded to up to eight suppliers. Lot 1 Chemicals generally as per core list in Doc 4d: Part B — Commercial response. Lot 2 Bio-chemicals generally as described in core list in Doc 4d: Part B Commercial response. Lot 3 Tissue cultures generally as described in core list in Doc 4d: Part B Commercial response. Lot 4 General consumables generally as described in core list in Doc 4d: Part B Commercial response. Lot 5 PPE and cleaning generally as described in core list in Doc 4d: Part B Commercial response. Lot 6 Pipettes, tips and servicing generally as described in core list in Doc 4d: Part B Commercial response. Lot 7 Glassware and ground glass generally as described in core list in Doc 4d: Part B Commercial response. Lot 8 Plastics generally as described in core list in Doc 4d: Part B Commercial response. Lot 9 Tissue culture plastics generally as described in core list in Doc 4d: Part B Commercial response. Lot 10 Oligos and primers generally as described in core list in Doc 4d: Part B Commercial response. Lot 11 DNA sequencing generally as described in core list in Doc 4d: Part B Commercial response.